Related Experiment Video
Updated: Aug 17, 2026

Myocardial Infarction and Functional Outcome Assessment in Pigs
Published on: April 25, 2014
Angioplasty versus thrombolysis for acute myocardial infarction
1Truman Medical Center, University of Missouri-Kansas City School of Medicine.
Insights
Direct angioplasty and thrombolytic therapy both reduce acute myocardial infarction mortality. Direct angioplasty is preferred for cardiogenic shock patients, while thrombolytic therapy followed by angioplasty is often best for most patients.
Area of Science:
- Cardiology
- Interventional Cardiology
- Acute Myocardial Infarction Management
Background:
- Acute myocardial infarction (AMI) is a leading cause of mortality worldwide.
- Reperfusion therapy, including direct angioplasty and thrombolytic therapy, is crucial for improving outcomes in AMI.
- Optimal reperfusion strategy may vary depending on patient subgroups and clinical presentation.
Purpose of the Study:
- To compare the effectiveness of direct angioplasty versus thrombolytic therapy in patients with acute myocardial infarction.
- To identify patient subgroups that benefit more from one reperfusion strategy over the other.
- To guide optimal treatment selection for acute myocardial infarction management.
Main Methods:
- Comparative analysis of direct angioplasty and thrombolytic therapy outcomes in acute myocardial infarction.
- Evaluation of treatment efficacy across different patient subgroups, including those with cardiogenic shock, previous bypass surgery, delayed presentation, and multivessel coronary artery disease.
- Assessment of infarct location (anterior vs. inferior) impact on therapeutic choice.
Main Results:
- Direct angioplasty is favored in patients with cardiogenic shock, with potential exceptions for the elderly or those with three-vessel disease. It is also preferred post-coronary bypass surgery.
- Thrombolytic therapy and direct angioplasty show similar effectiveness in patients presenting more than 6 hours after symptom onset or with multivessel coronary artery disease.
- Infarct location does not appear to influence the choice between thrombolytic therapy and direct angioplasty.
Conclusions:
- The choice between direct angioplasty and thrombolytic therapy for acute myocardial infarction should be individualized based on patient characteristics and clinical status.
- For most patients, initiating treatment with thrombolytic therapy followed by selective angioplasty when clinically indicated is considered the optimal approach.
- Further research may refine treatment algorithms for specific acute myocardial infarction patient populations.
Abstract:
Both direct angioplasty and thrombolytic therapy can decrease mortality from acute myocardial infarction, but certain subgroups of patients benefit more from one method than the other. Direct angioplasty is favored in patients in cardiogenic shock (with perhaps the exception of those who are elderly or have three-vessel coronary disease) and patients who have undergone previous coronary bypass surgery. Thrombolytic therapy and direct angioplasty seem to be equally effective in patients with acute myocardial infarction who present more than 6 hours after onset of symptoms or have multivessel coronary artery disease. The location of the infarct (anterior versus inferior) does not favor one therapy over the other. We believe that in most patients, the best approach is to begin with thrombolytic therapy and to follow that with selective application of angioplasty when it is clinically appropriate.
Related Concept Videos
Myocarditis III: Medical Management
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Peripheral Artery Disease III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Ischemic Stroke ll: Pathophysiology

